
Sign up to save your podcasts
Or
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150
4.9
111111 ratings
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150
320 Listeners
501 Listeners
123 Listeners
3,334 Listeners
1,143 Listeners
123 Listeners
188 Listeners
513 Listeners
366 Listeners
168 Listeners
68 Listeners
5 Listeners
182 Listeners
6 Listeners
18 Listeners